Cytomegalovirus Prevalence in the US

Cytomegalovirus Prevalence in the US Cytomegalovirus (CMV) is a common virus belonging to the herpesvirus family, and its prevalence in the United States is notably high. Despite often remaining unnoticed in healthy individuals, CMV can pose significant health risks to certain populations, particularly immunocompromised individuals and newborns. Understanding the scope of CMV prevalence in the US is crucial for public health awareness and for guiding preventive strategies.

Approximately half of all adults in the United States are infected with CMV by the age of 40. The infection is primarily transmitted through bodily fluids such as saliva, urine, blood, semen, and breast milk. Most infections occur during childhood or early adulthood, often without symptoms. Because of its high transmission rate and often asymptomatic nature, CMV has become a widespread health concern.

In healthy individuals, CMV typically remains dormant after initial infection, with the immune system controlling its activity. However, in immunocompromised populations—such as organ transplant recipients, HIV/AIDS patients, and cancer patients—the virus can reactivate or cause new infections that lead to serious complications. For example, CMV can cause tissue damage, pneumonia, gastrointestinal issues, and complications in the eyes, which can threaten vision.

Pregnant women are also a key concern in CMV prevalence. Congenital CMV infection occurs when the virus is transmitted from mother to fetus during pregnancy. It is one of the leading causes of birth defects and developmental disabilities in the US. Annually, about 1 in 200 babies are born with congenital CMV, and of these, approximately 1 in 5 may experience long-term health problems, including hearing loss and intellectual disabilities.

Despite its high prevalence, CMV is often underdiagnosed because its symptoms are nonspecific or absent altogether. Routine screening is not universally recommended, which complicates efforts to track its true prevalence. However, advances in diagnostic testing, suc

The image depicts a woman in a gym setting. She is smiling and appears to be engaged in an exercise routine, possibly on a treadmill given the blurred background indicative of motion.

h as polymerase chain reaction (PCR), have improved the ability to detect active infections, especially in high-risk groups.

Preventive measures focus on reducing transmission, especially among vulnerable populations. Practicing good hygiene, such as thorough handwashing after contact with bodily fluids, and avoiding sharing utensils or drinks with young children can lower the risk of infection. For pregnant women, screening and monitoring can help manage potential risks to the fetus.

Research continues into the development of vaccines and antiviral treatments to prevent and manage CMV infections effectively. Currently, there is no approved vaccine for general use, but several candidates are in clinical trials, holding promise for future prevention strategies.

In summary, the high prevalence of CMV in the US underscores the importance of awareness, early detection, and preventive measures. While most healthy individuals carry the virus without issue, its impact on pregnant women and immunocompromised people makes it a significant public health concern. Continued research and education are vital to controlling its spread and reducing associated health complications.

*The information on our website is not intended to direct people to diagnosis and treatment. Do not carry out all your diagnosis and treatment procedures without consulting your doctor. The contents do not contain information about the therapeutic health services of Acıbadem Health Group.